Research
Divergent activation of the RXFP1 relaxin receptor by protein and small-molecule agonists
Science · By James Osei-Owusu, Tristan Girbau, Xunan Wang, Jeffrey S. Smith, Pengxiang Shen, Sarah C. Erlandson, Amanda K. Williamson, Xiaojing Cong, Mark W. Grinstaff, Daniel E. Kahne, Cherine Bechara & Andrew C. Kruse ·
The Brief
- Study published in Science (Volume 394, Issue 6826, November 2026) on activation of the RXFP1 relaxin receptor.
- The title describes divergent activation of RXFP1 by protein agonists and by small-molecule agonists.
- Only the title and bibliographic details were available, so the specific mechanisms and results are not described here.
Why it matters
The study compares how protein and small-molecule agonists activate the RXFP1 relaxin receptor, which bears on how this receptor can be targeted.
Who’s affected
- pharmacologists and structural biologists
- researchers studying G protein-coupled receptor signaling
- #relaxin receptor
- #rxfp1
- #gpcr
- #agonists
- #pharmacology
Science, Volume 394, Issue 6826 , November 2026.